Orchestra BioMed Holdings, Inc. Accounts Payable
Orchestra BioMed Holdings, Inc. (OBIO) had Accounts Payable of $6.13 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable, Current $6.13M.
- 2026-03-31: Accounts Payable, Current $6.31M.
- 2025-12-31: Accounts Payable, Current $6.09M.
- 2025-09-30: Accounts Payable, Current $8.47M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.13M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $6.31M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $6.09M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $8.47M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $5.31M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $5.56M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $5.13M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $4.72M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $6.27M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $3.35M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $2.90M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $3.15M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $3.01M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.77M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $3.97M 10-K · filed 2024-03-27 | $376.93K 10-K · filed 2023-01-25 |
| 2022-09-30 | $281.56K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $170.66K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $103.61K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.39K 10-K · filed 2023-01-25 | |
| 2021-09-30 | $1.66K 10-Q/A · filed 2022-03-31 | |
| 2021-06-30 | $19.34K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $34.56K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $13.81K 10-K/A · filed 2022-03-31 | |
| 2020-09-30 | $1.45K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |